570
Views
12
CrossRef citations to date
0
Altmetric
Research Reports

Spectrum of ocular manifestations in cobalamin C and cobalamin A types of methylmalonic acidemia

, , , , , & show all
Pages 404-414 | Received 13 Jun 2015, Accepted 14 Nov 2015, Published online: 15 Mar 2016

References

  • Eggersdorfer M, Adam G, John M, et al. Vitamins; Ullmann’s encyclopedia of industrial chemistry. New York: Wiley-VCH Verlag GmbH & Co. KGaA, 2000
  • Lerner-Ellis JP, Tirone JC, Pawelek PD, et al. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. Nat Genet 2006;38:93–100.
  • Banerjee R. B12 trafficking in mammals: a for coenzyme escort service. ACS Chem Biol 2006;1:149–159.
  • Banerjee R, Gherasim C, Padovani D. The tinker, tailor, soldier in intracellular B12 trafficking. Curr Opin Chem Biol 2009;13:484–491.
  • Kim J, Gherasim C, Banerjee R. Decyanation of vitamin B12 by a trafficking chaperone. Proc Natl Acad Sci U S A 2008;105:14551–14554.
  • Kim J, Hannibal L, Gherasim C, et al. A human vitamin B12 trafficking protein uses glutathione transferase activity for processing alkylcobalamins. J Biol Chem 2009;284:33418–33424.
  • Carrillo-Carrasco N, Adams D, Venditti CP. Disorders of Intracellular Cobalamin Metabolism. 2008 Feb 25 [Updated 2013 Nov 21]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2016. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1328/
  • Carrillo-Carrasco N, Chandler RJ, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis 2012;35:91–102.
  • Horster F, Baumgartner MR, Viardot C, et al. Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res 2007;62:225–230.
  • Manoli I, Sloan JL, Venditti CP. Isolated Methylmalonic Acidemia. 2005 Aug 16 [Updated 2016 Jan 7]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2016. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1231/
  • Carmel R, Bedros AA, Mace JW, et al. Congenital methylmalonic aciduria – homocystinuria with megaloblastic anemia: observations on response to hydroxocobalamin and on the effect of homocysteine and methionine on the deoxyuridine suppression test. Blood 1980;55:570–579.
  • Robb RM, Dowton SB, Fulton AB, et al. Retinal degeneration in vitamin B12 disorder associated with methylmalonic aciduria and sulfur amino acid abnormalities. Am J Ophthalmol 1984;97:691–696.
  • Mitchell GA, Watkins D, Melancon SB, et al. Clinical heterogeneity in cobalamin C variant of combined homocystinuria and methylmalonic aciduria. J Pediatr 1986;108:410–415.
  • Ticho BH, Feist RM, Fishman GA. Nondetectable electroretinogram in combined methylmalonic aciduria and homocystinuria. Ann Ophthalmol 1992;24:180–181.
  • Traboulsi EI, Silva JC, Geraghty MT, et al. Ocular histopathologic characteristics of cobalamin C type vitamin B12 defect with methylmalonic aciduria and homocystinuria. Am J Ophthalmol 1992;113:269–280.
  • Andersson HC, Marble M, Shapira E. Long-term outcome in treated combined methylmalonic acidemia and homocystinemia. Genet Med 1999;1:146–150.
  • Patton N, Beatty S, Lloyd IC, et al. Optic atrophy in association with cobalamin C (cblC) disease. Ophthalmic Genet 2000;21:151–154.
  • Ricci D, Pane M, Deodato F, et al. Assessment of visual function in children with methylmalonic aciduria and homocystinuria. Neuropediatrics 2005;36:181–185.
  • Schimel AM, Mets MB. The natural history of retinal degeneration in association with cobalamin C (cbl C) disease. Ophthalmic Genet 2006;27:9–14.
  • Gaillard MC, Matthieu JM, Borruat FX. Retinal dysfunction in combined methylmalonic aciduria and homocystinuria (Cblc) disease: a spectrum of disorders. Klin Monbl Augenheilkd 2008;225:491–494.
  • Williams ZR, Hurley PE, Altiparmak UE, et al. Late onset optic neuropathy in methylmalonic and propionic acidemia. Am J Ophthalmol 2009;147:929–933.
  • Fuchs LR, Robert M, Ingster-Moati I, et al. Ocular manifestations of cobalamin C type methylmalonic aciduria with homocystinuria. J AAPOS 2012;16:370–375.
  • Aleman TS, Brodie F, Garvin C, et al. Retinal structure in cobalamin C disease: mechanistic and therapeutic implications. Ophthalmic Genet 2014;100:98–104.
  • Weisfeld-Adams JD, McCourt EA, Diaz GA, et al. Ocular disease in the cobalamin C defect: a review of the literature and a suggested framework for clinical surveillance. Mol Genet Metab 2015;114:537–546.
  • Korotkova N, Lidstrom ME. MeaB is a component of the methylmalonyl-CoA mutase complex required for protection of the enzyme from inactivation. J Biol Chem 2004;279:13652–13658.
  • Padovani D, Banerjee R. Assembly and protection of the radical enzyme, methylmalonyl-CoA mutase, by its chaperone. Biochemistry 2006;45:9300–9306.
  • Goodman SI, Moe PG, Hammond KB, et al. Homocystinuria with methylmalonic aciduria: two cases in a sibship. Biochem Med 1970;4:500–515.
  • Suormala T, Baumgartner MR, Coelho D, et al. The cblD defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis. J Biol Chem 2004;279:42742–42749.
  • Atkinson C, Miousse IR, Watkins D, et al. Clinical, biochemical, and molecular presentation in a patient with the cblD-homocystinuria inborn error of cobalamin metabolism. JIMD Rep 2014;17:77–81.
  • Alfadhel M, Lillquist YP, Davis C, et al. Eighteen-year follow-up of a patient with cobalamin F disease (cblF): report and review. Am J Med Genet A 2011;155A:2571–2577.
  • Marmor MF, Fulton AB, Holder GE, et al. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 2009;118:69–77.
  • Oh KT, Weleber RG, Stone EM, et al. Electroretinographic findings in patients with Stargardt disease and fundus flavimaculatus. Retina 2004;24:920–928.
  • Hood DC, Bach M, Brigell M, et al. ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition). Doc Ophthalmol 2012;124:1–13.
  • Merinero B, Perez B, Perez-Cerda C, et al. Methylmalonic acidaemia: examination of genotype and biochemical data in 32 patients belonging to mut, cblA or cblB complementation group. J Inherit Metab Dis 2008;31:55–66.
  • Martinez Alvarez L, Jameson E, Parry NR, et al. Optic neuropathy in methylmalonic acidemia and propionic acidemia. Br J Ophthalmol 2015;100:98–104.
  • Poloschek CM, Fowler B, Unsold R, et al. Disturbed visual system function in methionine synthase deficiency. Graefes Arch Clin Exp Ophthalmol 2005;243:497–500.
  • Rosenblatt DS, Aspler AL, Shevell MI, et al. Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC). J Inherit Metab Dis 1997;20:528–538.
  • Morel CF, Lerner-Ellis JP, Rosenblatt DS. Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. Mol Genet Metab 2006;88:315–321.
  • Lerner-Ellis JP, Anastasio N, Liu J, et al. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations. Hum Mutat 2009;30:1072–1081.
  • Wang X, Sun W, Yang Y, et al. A clinical and gene analysis of late-onset combined methylmalonic aciduria and homocystinuria, cblC type, in China. J Neurol Sci 2012;318:155–159.
  • Gerth C, Morel CF, Feigenbaum A, et al. Ocular phenotype in patients with methylmalonic aciduria and homocystinuria, cobalamin C type. J AAPOS 2008;12:591–596.
  • Carrillo-Carrasco N, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes. J Inherit Metab Dis 2012;35:103–114.
  • Pastore A, Martinelli D, Piemonte F, et al. Glutathione metabolism in cobalamin deficiency type C (cblC). J Inherit Metab Dis 2014;37:125–129.
  • Barot M, Gokulgandhi MR, Mitra AK. Mitochondrial dysfunction in retinal diseases. Curr Eye Res 2011;36:1069–1077.
  • Richard E, Jorge-Finnigan A, Garcia-Villoria J, et al. Genetic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC). Hum Mutat 2009;30:1558–1566.
  • Tsina EK, Marsden DL, Hansen RM, et al. Maculopathy and retinal degeneration in cobalamin C methylmalonic aciduria and homocystinuria. Arch Ophthalmol 2005;123:1143–1146.
  • Maestro de las Casas C, Epeldegui M, Tudela C, et al. High exogenous homocysteine modifies eye development in early chick embryos. Birth Defects Res A Clin Mol Teratol 2003; 67:35–40.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.